PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsNabriva Therapeutics
Nabriva Therapeutics(NBRV)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
XenletaLefamulin2020-07-272028-2031
Community-acquired infections
,
Bacterial pneumonia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lefamulin
healthy volunteers/patients
,
fibrosis
,
cystic fibrosis
,
infections
,
bacterial infections
,
mycoplasma infections
,
pleuropneumonia
,
mycoplasma genitalium
,
community-acquired pneumonia
,
pneumonia
Bevifimod
basal cell carcinoma
,
basal cell neoplasms
,
actinic keratosis
Lactams
neoplasms
,
hiv
,
tuberculosis
,
drug-related side effects and adverse reactions
,
sinusitis
,
otitis media
,
healthy volunteers/patients
,
otitis
,
infectious skin diseases
,
lung diseases
,
mycobacterium avium complex
,
mycobacterium avium-intracellulare infection
Trinessa
healthy volunteers/patients
Fluoroquinolone
healthy volunteers/patients
,
corneal ulcer
,
keratitis
,
inflammation
,
eye infections
,
bacterial conjunctivitis
,
cataract
,
keratoconjunctivitis sicca
,
dry eye syndromes
,
microbial drug resistance
Isoxaflutole
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use